Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;170(3):837-844.
doi: 10.1002/ohn.608. Epub 2023 Nov 29.

Impact of Sarcopenia on Survival of Patients With Malignant Salivary Glands Tumors

Vincenzo Abbate  1 , Stefania Troise  1 , Giulia Togo  1 , Simona Barone  1 , Paola Bonavolontà  1 , Daniela Pacella  2 , Luigi Angelo Vaira  3 , Umberto Committeri  1 , Alessandro Tel  4 , Lorenzo Ugga  5 , Massimo Robiony  4 , Luigi Califano  1 , Giovanni Dell'Aversana Orabona  1
Affiliations

Impact of Sarcopenia on Survival of Patients With Malignant Salivary Glands Tumors

Vincenzo Abbate et al. Otolaryngol Head Neck Surg. 2024 Mar.

Abstract

Objective: Malignant salivary glands tumors (MSGTs) are a quite rare and heterogeneous group of tumors. Management of these lesions remains controversial and challenging. Thus, finding new prognostic factors that can help to guide the decision-making process, appears to be paramount. The aim of this study was to evaluate the prognostic performance of preoperative sarcopenia to stratify MSGTs patients at high risk of disease progression.

Study design: Retrospective study.

Setting: A single-institution analysis (Maxillo-facial Surgery Unit, University of Naples Federico II).

Methods: The study consists of a retrospective analysis of 74 patients surgically treated for MSGTs. For all patients, the skeletal muscle index (SMI) was calculated and sarcopenia was defined as SMI < 41 in females and <43 in males. The correlation between sarcopenia and tumor variables was analyzed. The prognostic performance of sarcopenia was evaluated through survival Kaplan-Meier curves.

Results: Sarcopenia resulted statistically related to age (P < .001), tumor size (P < .001), lymph node metastases (P < .001), and American Joint Committee on Cancer tumor, node, metastasis stage (P < .001). Kaplan-Meier survival curves show that 47.3% of sarcopenic patients died before their final follow-up.

Conclusion: Data obtained from our study seem to confirm the correlation between sarcopenia and other high-risk features. The early detection of sarcopenia in patients with negative prognostic factors could be used to implement the support therapeutic strategies aimed at restore the clinical conditions of the patients. Sarcopenia may be routinely investigated before surgery to suggest the implementation of precautionary therapeutic strategies to improve the standard treatment response, reducing possible complications.

Keywords: inflammatory biomarkers; prognostic factors; salivary glands tumors; sarcopenia; skeletal muscle index.

PubMed Disclaimer

References

    1. Spitz MR, Batsakis JG. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110(1):45-49.
    1. Russo D, Di Crescenzo RM, Varricchio S, et al. Low-grade intraductal carcinoma of the parotid gland: a case report and literature review. Head Neck Pathol. 2021;15(4):1359-1371.
    1. Ali S, Palmer FL, Di Lorenzo M, Shah JP, Patel SG, Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol. 2014;21(9):3042-3048.
    1. Edge SB. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th ed. Springer; 2017.
    1. Toyoda H, Kumada T, Tada T, et al. Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy. J Hepatol. 2012;57(6):1251-1257.

LinkOut - more resources